| Authors: |
Grun CN; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA., Jain R; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.; Piton Therapeutics, Watertown, MA, USA., Schniederberend M; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA., Shoemaker CB; Department of Infectious Disease and Global Health, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, USA., Nelson B; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.; Orion Corporation, Turku, Finland., Kazmierczak BI; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA. barbara.kazmierczak@yale.edu.; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA. barbara.kazmierczak@yale.edu. |
